Clorox Company (The) (NYSE:CLX) was upgraded by Consumer Edge from a “neutral” rating to an “outperform” rating in a research report issued on Friday.

Other research analysts have also issued reports about the company. Jefferies Group LLC reaffirmed a “hold” rating and set a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Barclays PLC reaffirmed an “equal weight” rating and set a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BMO Capital Markets set a $150.00 target price on Clorox Company (The) and gave the stock a “buy” rating in a research report on Thursday, August 3rd. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. Clorox Company (The) currently has a consensus rating of “Hold” and an average price target of $128.72.

Clorox Company (CLX) opened at $132.05 on Friday. The stock has a market capitalization of $17,026.39, a price-to-earnings ratio of 23.79, a P/E/G ratio of 3.60 and a beta of 0.39. The company has a current ratio of 1.10, a quick ratio of 0.77 and a debt-to-equity ratio of 3.02. Clorox Company has a 12-month low of $111.77 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.41 by $0.05. The business had revenue of $1.50 billion during the quarter, compared to analyst estimates of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. Clorox Company (The)’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period last year, the company earned $1.36 EPS. equities research analysts anticipate that Clorox Company will post 5.58 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Clorox Company (The) (CLX) Stock Rating Upgraded by Consumer Edge” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.watchlistnews.com/clorox-company-the-clx-stock-rating-upgraded-by-consumer-edge/1697714.html.

In other news, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the sale, the executive vice president now directly owns 22,069 shares in the company, valued at approximately $3,056,777.19. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the sale, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 41,293 shares of company stock valued at $5,560,303. 1.00% of the stock is currently owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in Clorox Company (The) by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock valued at $1,936,595,000 after purchasing an additional 369,918 shares during the last quarter. BlackRock Inc. boosted its stake in Clorox Company (The) by 1,402.2% during the 1st quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after purchasing an additional 9,698,542 shares during the last quarter. State Street Corp boosted its stake in Clorox Company (The) by 2.2% during the 1st quarter. State Street Corp now owns 7,648,999 shares of the company’s stock valued at $1,031,304,000 after purchasing an additional 167,689 shares during the last quarter. Parnassus Investments CA boosted its stake in Clorox Company (The) by 1.7% during the 3rd quarter. Parnassus Investments CA now owns 4,451,150 shares of the company’s stock valued at $587,151,000 after purchasing an additional 76,236 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its stake in Clorox Company (The) by 5.3% during the 2nd quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock valued at $587,934,000 after purchasing an additional 221,168 shares during the last quarter. Institutional investors and hedge funds own 71.54% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.